Bioage Labs, Stock Performance
| BIOA Stock | 19.14 0.70 3.80% |
On a scale of 0 to 100, BioAge Labs, holds a performance score of 3. The firm shows a Beta (market volatility) of 0.68, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, BioAge Labs,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding BioAge Labs, is expected to be smaller as well. Please check BioAge Labs,'s total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to make a quick decision on whether BioAge Labs,'s price patterns will revert.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in BioAge Labs, are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, BioAge Labs, sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 3.8 | Five Day Return (1.85) | Year To Date Return 4.53 | Ten Year Return 4.53 | All Time Return 4.53 |
1 | BioAge Labs director Healy James buys over 10m in stock | 09/27/2024 |
2 | This IPO Biotech Stock Could Be the Next Eli Lilly | 10/03/2024 |
3 | Goldman Sachs, Morgan Stanley bullish on BioAge, cite Lilly relationship | 10/21/2024 |
4 | BioAge Labs to Present at Upcoming Investor Conferences | 11/21/2024 |
| Begin Period Cash Flow | 27.6 M |
BioAge |
BioAge Labs, Relative Risk vs. Return Landscape
If you would invest 1,831 in BioAge Labs, on August 26, 2024 and sell it today you would earn a total of 83.00 from holding BioAge Labs, or generate 4.53% return on investment over 90 days. BioAge Labs, is currently generating 0.2515% in daily expected returns and assumes 5.5137% risk (volatility on return distribution) over the 90 days horizon. In different words, 49% of stocks are less volatile than BioAge, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
BioAge Labs, Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioAge Labs,'s investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BioAge Labs,, and traders can use it to determine the average amount a BioAge Labs,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0456
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BIOA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.51 actual daily | 49 51% of assets are more volatile |
Expected Return
| 0.25 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average BioAge Labs, is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioAge Labs, by adding it to a well-diversified portfolio.
BioAge Labs, Fundamentals Growth
BioAge Stock prices reflect investors' perceptions of the future prospects and financial health of BioAge Labs,, and BioAge Labs, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioAge Stock performance.
| Current Valuation | 539.05 M | ||||
| Shares Outstanding | 34.17 M | ||||
| Price To Earning | (0.84) X | ||||
| EBITDA | (45.81 M) | ||||
| Net Income | (63.85 M) | ||||
| Cash And Equivalents | 4.63 M | ||||
| Cash Per Share | 0.04 X | ||||
| Total Debt | 53.25 M | ||||
| Debt To Equity | 172.10 % | ||||
| Current Ratio | 1.35 X | ||||
| Book Value Per Share | (114.37) X | ||||
| Cash Flow From Operations | (37.36 M) | ||||
| Earnings Per Share | (5.40) X | ||||
| Market Capitalization | 674.12 M | ||||
| Total Asset | 25.92 M | ||||
| Retained Earnings | (181.7 M) | ||||
| Working Capital | (32.86 M) | ||||
| Current Asset | 10.84 M | ||||
| Current Liabilities | 29.68 M | ||||
About BioAge Labs, Performance
By analyzing BioAge Labs,'s fundamental ratios, stakeholders can gain valuable insights into BioAge Labs,'s financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BioAge Labs, has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BioAge Labs, has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 90.69 | 86.16 | |
| Return On Tangible Assets | (2.46) | (2.34) | |
| Return On Capital Employed | 1.50 | 1.58 | |
| Return On Assets | (2.46) | (2.34) | |
| Return On Equity | 0.37 | 0.39 |
Things to note about BioAge Labs, performance evaluation
Checking the ongoing alerts about BioAge Labs, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BioAge Labs, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioAge Labs, had very high historical volatility over the last 90 days | |
| BioAge Labs, has high likelihood to experience some financial distress in the next 2 years | |
| BioAge Labs, has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Net Loss for the year was (63.85 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| BioAge Labs, currently holds about 4.63 M in cash with (37.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| Latest headline from gurufocus.com: BioAge Labs to Present at Upcoming Investor Conferences |
- Analyzing BioAge Labs,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioAge Labs,'s stock is overvalued or undervalued compared to its peers.
- Examining BioAge Labs,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioAge Labs,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioAge Labs,'s management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioAge Labs,'s stock. These opinions can provide insight into BioAge Labs,'s potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for BioAge Stock analysis
When running BioAge Labs,'s price analysis, check to measure BioAge Labs,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAge Labs, is operating at the current time. Most of BioAge Labs,'s value examination focuses on studying past and present price action to predict the probability of BioAge Labs,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAge Labs,'s price. Additionally, you may evaluate how the addition of BioAge Labs, to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |